BridgeMD
New treatment option for Cigarette Smoking
Official title Smoking Cessation for Fathers of Sick Children
ClinicalTrials.gov ID: NCT07014124
What this study is testing
- What it's testing
- The project aims to develop and examine the feasibility, acceptability, and preliminary effectiveness of a proactive intervention model combined brief advice, nicotine replacement therapy sampling and mHealth-based individual counselling in increasing smoking abstinence for fathers of sick children.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- for parents：
- Parents (mainly fathers) aged ≥18 years and smoke at least one cigarette (including alternative tobacco products) daily in the past seven days
- Living with a child aged \<18 years who attended the clinic or were admitted to the pediatric ward
- Hong Kong residents able to read and communicate in Cantonese or Putonghua
- Owned a smartphone and can use an instant messaging app (e.g., WhatsApp, Facebook) for children
You likely can't join if
- for parents
- Smokers having a history of psychiatric/psychological disease or currently on regular psychotropic medications
- Smokers using smoking cessation medications or other smoking cessation services or projects Exclusion criteria for children
- Children who already have serious health diseases (e.g.chronic disease, genetic disease)
- Children who are participating in other clinical trials that may affect the results of this study
- Children who live in certain environments, such as those living in highly contaminated areas or areas with other potential disease-causing factors
See the full eligibility criteria
- for parents：
- Parents (mainly fathers) aged ≥18 years and smoke at least one cigarette (including alternative tobacco products) daily in the past seven days
- Living with a child aged \<18 years who attended the clinic or were admitted to the pediatric ward
- Hong Kong residents able to read and communicate in Cantonese or Putonghua
- Owned a smartphone and can use an instant messaging app (e.g., WhatsApp, Facebook) for children
- Children aged \<18 years who attended the clinic or were admitted to the pediatric ward
- Lives with at least one or more parents who smoke at least one cigarette (including alternative tobacco products) daily in the past seven days
- Able to provide biochemical samples (e.g. saliva) for purpose of research
- for parents
- Smokers having a history of psychiatric/psychological disease or currently on regular psychotropic medications
- Smokers using smoking cessation medications or other smoking cessation services or projects Exclusion criteria for children
- Children who already have serious health diseases (e.g.chronic disease, genetic disease)
- Children who are participating in other clinical trials that may affect the results of this study
- Children who live in certain environments, such as those living in highly contaminated areas or areas with other potential disease-causing factors
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Pokfulam, Hong Kong
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Pokfulam, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.